H35.129

Clinical Causes: Premature birth (before 37 weeks of gestation) Low birth weight (less than 1500 grams or approximately 3 pounds 5 ounces) Oxygen therapy administered to premature infants, especially if high levels are used for extended periods Genetic factors may also play a role in susceptibility, although the primary cause is related to premature development Environmental factors such as fluctuations in blood oxygen levels

Key Symptoms: Usually no noticeable symptoms in early stages Potential for vision difficulties as the disease progresses, though often asymptomatic initially In some cases, abnormal eye movements or crossed eyes (strabismus) may occur later If the condition worsens, signs such as increased eye redness or bulging eyes might appear, but these are less common in early stages

Diagnosis Path: The diagnosis of Stage 1 ROP is made through a comprehensive eye examination, usually performed by a pediatric ophthalmologist. The examination involves dilating the infant’s pupils to allow a detailed view of the retina. Retinal changes such as a demarcation line or a very shallow ridge are characteristic of Stage 1. Regular screenings are vital for premature infants to detect progression or resolution of the disease early on.

Treatment Protocols: Stage 1 ROP often resolves on its own without intervention, but careful monitoring is essential to identify any progression to more severe stages. If the disease advances, treatments might include laser therapy or cryotherapy to prevent further abnormal blood vessel growth and potential vision loss. In addition, managing oxygen therapy during neonatal care is crucial in reducing the risk of ROP development. Follow-up visits with a pediatric ophthalmologist ensure that the retina’s condition is closely observed until it stabilizes.